Skip to main content
. Author manuscript; available in PMC: 2009 Mar 1.
Published in final edited form as: Neuropharmacology. 2007 Nov 5;54(3):487–496. doi: 10.1016/j.neuropharm.2007.10.019

Table 1.

Effects on cardiovascular, metabolic and thermogenic variables elicited by microinjection of NMDA into the intermediolateral cell column at the fourth thoracic segment.

Control NMDA into T4 IML
BAT SNA (% control) 100 +492 ± 52 *
Expired CO2 (%) 4.6 ± 0.1 +0.1 ± 0.0 *
HR (beats min−1) 391 ± 9 +48 ± 5 *
MAP (mmHg) 102 ± 4 +8 ± 1 *

Values are mean ± SE (n=32) for physiological variables in the control condition and the peak changes within 10 minutes after the microinjection of NMDA into the intermediolateral cell column at the fourth thoracic segment on the right side (ipsilateral to the recorded nerve).

*

indicates p<0.05, compared to the control condition.